Literature DB >> 11402233

Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections.

D J White1, A R Habib, A Vanthuyne, S Langford, M Symonds.   

Abstract

Patients with vaginitis due to highly azole resistant Candida glabrata can be particularly difficult to treat. We describe three cases of longstanding vaginal candidiasis due to C glabrata. These had failed to respond to local and systemic antifungals. Flucytosine (1 g) and amphotericin B (100 mg) formulated in lubricating jelly base in a total 8 g delivered dose, was used per vagina once daily for 14 days with significant improvement, both clinically and microbiologically.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402233      PMCID: PMC1744305          DOI: 10.1136/sti.77.3.212

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  9 in total

1.  What to do with the patient with recurrent vulvovaginal candidiasis.

Authors:  J S Bingham
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

2.  Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.

Authors:  V Redondo-Lopez; M Lynch; C Schmitt; R Cook; J D Sobel
Journal:  Obstet Gynecol       Date:  1990-10       Impact factor: 7.661

3.  Susceptibility of Candida species isolated from female prostitutes with vulvovaginitis to antifungal agents and boric acid.

Authors:  L Otero; A Fleites; F J Méndez; V Palacio; F Vázquez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-01       Impact factor: 3.267

4.  Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata.

Authors:  D Kerridge; R O Nicholas
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

Review 5.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

6.  Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.

Authors:  D J White; E M Johnson; D W Warnock
Journal:  Genitourin Med       Date:  1993-04

7.  Topical flucytosine therapy for chronic recurrent Candida tropicalis infections.

Authors:  B J Horowitz
Journal:  J Reprod Med       Date:  1986-09       Impact factor: 0.142

8.  Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.

Authors:  M E Lynch; J D Sobel
Journal:  J Med Vet Mycol       Date:  1994

9.  Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida.

Authors:  A M Geiger; B Foxman; J D Sobel
Journal:  Genitourin Med       Date:  1995-10
  9 in total
  6 in total

1.  Effects of antifungal agents alone and in combination against Candida glabrata strains susceptible or resistant to fluconazole.

Authors:  Izabel Almeida Alves; Laíssa Arévalo Bandeira; Débora Alves Nunes Mario; Laura Bedin Denardi; Louise Vignoles Neves; Janio Morais Santurio; Sydney Hartz Alves
Journal:  Mycopathologia       Date:  2012-04-22       Impact factor: 2.574

2.  Combination of Miconazole and Domiphen Bromide Is Fungicidal against Biofilms of Resistant Candida spp.

Authors:  Jana Tits; Freya Cools; Kaat De Cremer; Katrijn De Brucker; Judith Berman; Kristof Verbruggen; Bert Gevaert; Paul Cos; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

3.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

Review 4.  Local treatment of vulvovaginal candidosis : general and practical considerations.

Authors:  José das Neves; Eugénia Pinto; Branca Teixeira; Gustavo Dias; Patrocínia Rocha; Teresa Cunha; Bárbara Santos; Maria H Amaral; Maria F Bahia
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 5.  Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated Cement.

Authors:  Richard H Drew; John R Perfect
Journal:  J Fungi (Basel)       Date:  2022-02-21

Review 6.  Review on Plant-Based Management in Combating Antimicrobial Resistance - Mechanistic Perspective.

Authors:  Masita Arip; Malarvili Selvaraja; Mogana R; Lee Fang Tan; Mun Yee Leong; Puay Luan Tan; Vi Lien Yap; Sasikala Chinnapan; Ng Chin Tat; Maha Abdullah; Dharmendra K; Najwan Jubair
Journal:  Front Pharmacol       Date:  2022-09-29       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.